Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial

J Natl Cancer Inst. 1992 Jun 3;84(11):893-4. doi: 10.1093/jnci/84.11.893.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / toxicity*
  • Dacarbazine / administration & dosage
  • Dacarbazine / toxicity*
  • Drug Evaluation
  • Female
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / toxicity*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Middle Aged
  • Neoplasm Staging
  • Outpatients
  • Sex Characteristics

Substances

  • Interleukin-2
  • Dacarbazine